Physician profile
Sharon D Ramos
NPI 1093008849
$1,372.95
in general payments reported to CMS, 2019-2025
15 companies · $228 in 2025
The $228 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.00 · 2020: $124 · 2021: $55.81 · 2022: $248 · 2023: $400 · 2024: $275 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $903.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $903.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $547.53 | 2020-2025 | |
| Stryker Corporation | $219.48 | 2020-2025 | Xpress Loprofile |
| Optinose US, INC. | $127.26 | 2022-2024 | |
| Medtronic, INC. | $88.25 | 2024-2025 | Propel, Pteye Parathyroid Detection System |
| Genzyme Corporation | $78.37 | 2022-2025 | |
| Inspire Medical Systems, INC. | $51.40 | 2025 | Inspire |
| Kaleo, INC. | $42.91 | 2022-2024 | Auvi-Q |
| Intersect Ent, INC. | $42.85 | 2020 | |
| Senseonics, Incorporated | $42.00 | 2019 | |
| Cochlear Americas | $39.03 | 2023 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
| Karl Storz Endoscopy-America | $22.44 | 2025 | |
| Glaxosmithkline, LLC. | $20.21 | 2023 | Nucala |
| Astrazeneca Pharmaceuticals LP | $18.57 | 2025 | Tezspire |
| Regeneron Healthcare Solutions, INC. | $17.89 | 2025 | Dupixent |
| Medtronic USA, INC. | $14.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Ramos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.